Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY ® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY ® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New#Teva #Presents #Latest #Schizophrenia #Portfolio #Data #Including #RealWorld #Outcomes #UZEDY #risperidone #Showing #Rates #Longer #Time #Relapse #Compared #Oral #Treatment #Options